Skip to main content
Caplight Logo









T3D Therapeutics, Inc.

T3D Therapeutics, Inc.

Private
North CarolinaHealthcare & Life Scienceshttps://www.t3dtherapeutics.com/

Last Round

Grant

Oct 4, 2022

Total Funding Raised

$27.2M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

T3D Therapeutics, Inc. is a clinical-stage drug development company that develops a drug therapy designed to stop and reverse the course of Alzheimer's disease.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Clinical Trials, Biotechnology

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

Alzheimer's disease treatmentAlzheimer's drugsmall molecule drugclinical stage pharmabiotechneuro-metabolic disorderbrain insulin resistancePPAR agonistoral drugneurodegenerative diseasedrug developmentdrug pipelineHuntington's Diseaseamyloid plaquestau tangles

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

T3D Therapeutics, Inc. Comparables

Compare T3D Therapeutics, Inc. with similar companies based on industry and business-model similarity.

T3D Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cerecin
81%
BioVie Inc.
79%
Aquinnah Pharmaceuticals
78%

T3D Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 4, 2022
VC RoundAug 26, 2022
GrantAug 27, 2020
Series BNov 4, 2019
GrantMay 20, 2019
VC Round
Jan 12, 2018

T3D Therapeutics, Inc. Investors

Notable investors and investment history

T3D Therapeutics, Inc. investors
InvestorRounds
National Institute on AgingGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 176% MoM.

  • May 12, 2026

    Monthly visitors grew 70% MoM.

T3D Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

T3D Therapeutics, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about T3D Therapeutics, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNorth Carolina
Employee Range12
Year Founded2013
Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?